Wednesday, December 09, 2020 9:20:24 AM
Please don't be a pump-n-dump.
It is, what it is.
Recent XBIO News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:47:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 12:05:18 PM
- Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform • ACCESS Newswire • 05/13/2026 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:30:34 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/24/2026 09:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 09:00:19 PM
- Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting • ACCESS Newswire • 04/22/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:00:27 PM
- Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results • ACCESS Newswire • 03/13/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 09:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 10:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 10:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 10:00:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/11/2025 10:01:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 10:00:43 PM
- Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting • ACCESS Newswire • 12/11/2025 10:00:00 PM
- Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform • ACCESS Newswire • 11/19/2025 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:45:28 PM
- Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 01:45:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/31/2025 08:20:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/31/2025 08:10:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 12:48:56 PM
- Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock • ACCESS Newswire • 10/10/2025 01:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/10/2025 01:28:19 PM
